1/15
Why can cefepime cause neurological toxicity?

And why is renal failure the main risk factor for this complication?

The answer requires us to learn about cefepime's structure and why it unexpectedly binds to a certain CNS receptor.

#MedTwitter #Tweetorial
2/
Let's establish a few facts about cefepime:

đŸ”ș4th generation cephalosporin antibiotic
đŸ”șExcretion = exclusively in the urine (mostly as unchanged drug)
đŸ”șReadily crosses the blood-brain barrier (so it easily accesses the brain)

https://pubmed.ncbi.nlm.nih.gov/7785999/ 
3/
The first report of cefepime neurotoxicity was in 1999.

A patient w/ renal failure received high doses of cefepime and then developed encephalopathy, tremors, myoclonic jerks, and tonic-clonic seizures.

✅All symptoms resolved after hemodialysis.

https://pubmed.ncbi.nlm.nih.gov/10489256/ 
4/
Cefepime neurotoxicity is surprisingly common, occurring in up to 15% of treated critically ill patients (w/ symptoms varying from encephalopathy to seizures).

💡The main risk factors = renal failure and lack of dose adjustment for renal function.

https://pubmed.ncbi.nlm.nih.gov/24200036/ 
5/
What about cefepime induces neurotoxicity?

One clue is that it's not the only antibiotic that causes neurotoxicity, particularly seizures.

This actually is a class effect w/ other beta-lactam antibiotics (including penicillins and carbapenems).

https://pubmed.ncbi.nlm.nih.gov/9330839/ 
6/
Recall that beta-lactam antibiotics all share a common structural feature: a beta-lactam ring.

https://pubmed.ncbi.nlm.nih.gov/18676578/ 
7/
A 1971 study in cats implicated beta-lactam rings as the source of neurotoxicity.

High doses of penicillin were used to induce seizures.

🔑But pre-incubation w/ the enzyme beta-lactamase (disrupts the beta-lactam ring) blocked all seizure activity.

https://pubmed.ncbi.nlm.nih.gov/5105512/ 
8/
So why can beta-lactam antibiotics like cefepime cause neurotoxicity?

It turns that they block the binding of the inhibitory neurotransmitter gamma aminobutyric acid (GABA) to its receptor.     

🔑Cephalosporins block GABA particularly effectively.

https://pubmed.ncbi.nlm.nih.gov/2988433/ 
9/
The GABA receptor has two subtypes (A and B), and the A subtype functions as a ligand-gated Cl⁻ ion channel.

Cefepime binds to the GABA-A receptor and blocks Cl⁻ influx, which correlates with its ability to induce seizure activity.

https://pubmed.ncbi.nlm.nih.gov/12871648/ 
10/
We've established that cefepime blocks GABA.

This induces neuro-excitation leading to seizures and other neurotoxic manifestations such as tremors and encephalopathy.

💡But why is there such a strong link with renal failure?
11/
An obvious explanation would be that, since cefepime is renally cleared, elevated serum and CNS drug levels build up.

This is supported by the observation that cefepime and other cephalosporins block GABA in a concentration-dependent manner.

https://pubmed.ncbi.nlm.nih.gov/12871648/ 
12/
But increased drug levels might not be the only reason that patients w/ renal failure are predisposed to neurotoxicity.

The milieu around neurons seems to matter as well.
13/
This experiment in rat brain slices simulated a "renal" milieu by using a hyperkalemic medium around neurons.

âšĄïžExposure to higher potassium levels significantly increased the ability of cefepime to induce epileptiform discharges.

https://pubmed.ncbi.nlm.nih.gov/29625107/ 
14/
Let's ask one final question.

Why can cefepime (and other beta-lactam antibiotics) block the GABA receptor?

Exactly why hasn't been well-studied but it likely reflects sufficient structural similarity w/ GABA.

https://pubmed.ncbi.nlm.nih.gov/16261307/ 
15/
🧠Cefepime induces neurotoxicity by blocking the GABA receptor, similar to other beta-lactam antibiotics
🧠This results from structural similarities between GABA and the beta-lactam ring
🧠Renal failure = main risk factor b/c of âŹ†ïžÂ drug levels +/- hyperkalemia
You can follow @AvrahamCooperMD.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.